|Bid||90.76 x 1100|
|Ask||91.80 x 800|
|Day's range||90.91 - 92.90|
|52-week range||70.89 - 95.72|
|Beta (5Y monthly)||0.46|
|PE ratio (TTM)||32.17|
|Earnings date||27 Apr 2022 - 02 May 2022|
|Forward dividend & yield||2.76 (3.05%)|
|Ex-dividend date||14 Mar 2022|
|1y target est||95.73|
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss Moody's outlook for pharmaceutical industry as well as reports that Pfizer is looking to provide additional COVID-19 vaccine doses.
Walgreens Boots (WBA) reports better-than-expected Q3 earnings, with robust sales contributions from the International and Walgreens Health segments.
An FDA panel recommends updating COVID-19 booster shots. EU approvals for Sanofi's (SNY) two new drugs and expanded use of Merck's (MRK) Keytruda and Novartis' (NVS) Cosentyx.